Overview | Medtronic

Medtronic Investors

Creating
Long-term
Shareholder
Value

Our leading technologies and services create value on a global scale.

Latest Investor Information

September 24, 2018

Q&A Session from TCT with the Medtronic CVG Executive Management Team

September 26, 2018

Q&A Session from NASS with the Medtronic RTG Executive Management Team

September 14, 2018

Medtronic plc at Morgan Stanley 16th Annual Global Healthcare Conference

June 05, 2018

Institutional Investor & Analyst Day

Latest Press Releases

October 21, 2018	Medtronic Co-Founder Earl Bakken Passes Away at Age 94
October 16, 2018	Medtronic Launches the Control Workflow(SM) to Help Eliminate Oral Opioids and Provide Effective Pain Relief
September 25, 2018	Medtronic Launches the Infinity(TM) OCT Spinal System
September 24, 2018	Medtronic Builds on TAVR Clinical Evidence Portfolio with Five-Year CoreValve Durability Data and Complete Two-Year Outcomes in Intermediate Risk Aortic Stenosis Patients

Medtronic ESG & Corporate Citizenship Highlights

Medtronic Marks a Decade on the North American Dow Jones Sustainability Index (DJSI)

Opportunities to Obtain Irish Dividend Withholding Tax (DWT) Exemption

Important Information on the Irish Dividend Withholding Tax.

QUARTERLY

RESULTS

Medtronic Q1 revenue results and financial tables.

INVESTOR

FUNDAMENTALS

View snapshots of revenue and earnings, trading statistics, balance sheet, income statement, cash flow and ratios.

INSTITUTIONAL
INVESTOR AND
ANALYST MEETING
2018

Promising therapy and product innovation detailed by company leaders
READ HIGHLIGHTS

ACCESS WEBCAST REPLAY

img.alt

Sustainability Index Endorsements

Read more about our Sustainability efforts.

img.alt

Medtronic Spotlight

Medtronic CEO, Omar Ishrak sits down with CNBC’s Jim Cramer, to talk about the company’s analyst day and it’s fastest growing products.

img.alt

History of Medtronic

A video history of the company.

Investor Contacts

Stock Transfer Agent

EQ Shareowner Services
+1 888-648-8154

Medtronic Investor Relations Department

investor.relations@medtronic.com

+1 763-505-2692

Ryan Weispfenning

Vice President, Investor Relations